Table 1.
Summary of mAb improvements in tested outcome measures.
| Outcome measure | Syn-O1 | Syn-O2 | Syn-O4 | Syn-F1 | Syn-F2 | |
|---|---|---|---|---|---|---|
| Total α-syn levels improved vs. vehicle | Neocortex | ✓ | ✓ | ✓ | ||
| Hippocampus | ✓ | ✓ | ||||
| Striatum | ✓ | ✓ | ✓ | |||
| S. nigra | ✓ | ✓ | ✓ | |||
| PK-treated α-syn levels improved vs. vehicle | Neocortex | ✓ | ✓ | |||
| Hippocampus | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Striatum | ✓ | ✓ | ✓ | |||
| S. nigra | ||||||
| α-Syn levels improved vs. vehicle (ELISA) | t-α-syn | ✓ | ||||
| h-α-syn | ✓ | |||||
| Oligo-α-syn | ✓ | ✓ | ✓ | ✓ | ✓ | |
| pS129-α-syn | ||||||
| Aggregated α-syn | ✓ | ✓ | ✓ | |||
| Rescue neurodegeneration | NeuN | ✓ | ✓ | ✓ | ||
| Rescue neuroinflammation | GFAP | ✓ | ✓ | |||
| Iba-1 | ✓ | |||||
| Iba-1 ramification | ✓ | ✓ | ||||
| Increase colocalization synapsin I and synaptophysin | ✓ | ✓ | ✓ | |||
| Reduce colocalization synaptophysin and α-syn | ✓ | ✓ | ✓ | |||
| Normalizing behavior | Total activity | ✓ | ✓ | ✓ | ||
| Rearing | ||||||
| Thigmotaxis |